Institute for Translational Vaccinology:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Institute for Translational Vaccinology - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9434
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オランダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Institute for Translational Vaccinology (Intravacc) is a nonprofit research and development organization that concentrates on the development of vaccines. The organization’s services include technology transfer, exploratory and clinical research and regulatory support. It also provides novel research and has various development programs on vaccine delivery and formulation. Intravacc’s research and development programs comprise global health, bacterial and viral vaccines, polio center, animal models and 3R research, and vaccine formulation and delivery. The organization conducts research in various areas such as bacterial vaccine technology, viral vaccine technology, novel vaccines and clinical immunology. The organization works in collaboration with pharmaceutical, biotechnology, governments and public institutions to develop novel vaccines. Intravacc is headquartered in Bilthoven, the Netherlands.

Institute for Translational Vaccinology – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Institute for Translational Vaccinology, Medical Devices Deals, 2012 to YTD 2018 9
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Expres2ion Biotech and Institute for Translational Vaccinology Enter into Agreement 11
Abera Bioscience Enters into Partnership with Institute for Translational Vaccinology 12
Intravacc And MyLife Technologies Enter Into Co-Development Agreement For Intradermal Vaccination Technology 13
Intravacc Partners with International Vaccine Institute 14
Licensing Agreements 15
Sinovac Biotech Enters Into Licensing Agreement With Intravacc For Sabin Inactivated Polio Vaccine 15
Intravacc Enters into Licensing Agreement with Crucell Holland 16
Intravacc Enters into Licensing Agreement with ViciniVax 17
Institute for Translational Vaccinology – Key Competitors 18
Institute for Translational Vaccinology – Key Employees 19
Institute for Translational Vaccinology – Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Corporate Communications 21
May 04, 2017: Thijs Veerman CEO at Intravacc 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Key Facts 2
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Institute for Translational Vaccinology, Deals By Therapy Area, 2012 to YTD 2018 8
Institute for Translational Vaccinology, Medical Devices Deals, 2012 to YTD 2018 9
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Expres2ion Biotech and Institute for Translational Vaccinology Enter into Agreement 11
Abera Bioscience Enters into Partnership with Institute for Translational Vaccinology 12
Intravacc And MyLife Technologies Enter Into Co-Development Agreement For Intradermal Vaccination Technology 13
Intravacc Partners with International Vaccine Institute 14
Sinovac Biotech Enters Into Licensing Agreement With Intravacc For Sabin Inactivated Polio Vaccine 15
Intravacc Enters into Licensing Agreement with Crucell Holland 16
Intravacc Enters into Licensing Agreement with ViciniVax 17
Institute for Translational Vaccinology, Key Competitors 18
Institute for Translational Vaccinology, Key Employees 19

List of Figures
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Institute for Translational Vaccinology, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Institute for Translational Vaccinology:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • China Health Group Inc (8225):企業の財務・戦略的SWOT分析
    China Health Group Inc (8225) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Biosceptre International Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Biosceptre International Ltd (Biosceptre) is a biotechnology company that develops antibody technologies for applications in the diagnosis and treatment of cancer. The company develops imaging technologies to detect and monitor cancer. Its diagnostic products are used for the detection of va …
  • CLP Holdings Ltd (2)-エネルギー分野:企業M&A・提携分析
    Summary CLP Holdings Limited (CLP) is an investor and operator in the energy sector of Asia Pacific region. The company invests in power generation, transmission and distribution, and electricity and gas retail activities. Its portfolio includes equity generating and purchase capacities. CLP’s gener …
  • Daqo New Energy Corp (DQ):電力:M&Aディール及び事業提携情報
    Summary Daqo New Energy Corp (Daqo Cayman) is a manufacturer of polysilicon and solar wafers. Through tolling agreements, the company also offers wafer original equipment manufacturer (OEM) services to external customers. It sells its products to solar cell and solar module manufacturers. Daqo Cayma …
  • Sensus Healthcare Inc (SRTS):医療機器:M&Aディール及び事業提携情報
    Summary Sensus Healthcare Inc (Sensus) designs, manufactures and markets proprietary medical devices for the treatment of various types of cancers and skin diseases. The company offers superficial radiation therapy (SRT) technology based non-surgical treatment options for patients suffering from var …
  • Israel Institute of Technology:製薬・医療:M&Aディール及び事業提携情報
    Summary Israel Institute of Technology (Technion) is a research university that offers science and technology programs. The university offers various undergraduate and graduate programs in biology, biomedical engineering, biotechnology and food engineering, chemical engineering, and medicine and env …
  • Mediware Information Systems Inc-製薬・医療分野:企業M&A・提携分析
    Summary Mediware Information Systems Inc (Mediware) is a healthcare solutions company that designs, develops and commercializes specialized healthcare software. It provides software to healthcare and human service providers and payers. The company’s portfolio of solutions are equipped in blood banks …
  • Packages Limited:企業の戦略・SWOT・財務情報
    Packages Limited - Strategy, SWOT and Corporate Finance Report Summary Packages Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Rubicon Research Pvt Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Rubicon Research Pvt Ltd (Rubicon), a subsidiary of Everstone Capital Management, is a drug delivery technology company that develops, manufactures and markets next-generation pharmaceutical products. The company’s products include central nervous system, cardiovascular, cough, cold and anti …
  • Pacific Drilling SA (PACD):企業の財務・戦略的SWOT分析
    Summary Pacific Drilling SA (Pacific Drilling) is an offshore drilling company that offers ultra deepwater drilling services to the oil and natural gas industry. The company provides contract services for floating rig drilling in ultra deepwater through its drill ships. It rents its drilling rigs, r …
  • AssetCo plc (ASTO):企業の財務・戦略的SWOT分析
    Summary AssetCo plc (AssetCo) is a business and consumer service provider that offers fire fighting solutions. The company offers provision of management and resources to the fire and emergency services. It also provides outsourced fire and rescue services including the provision of personnel, train …
  • Beach Energy Ltd (BPT):企業の財務・戦略的SWOT分析
    Beach Energy Ltd (BPT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Stille AB (STIL):医療機器:M&Aディール及び事業提携情報
    Summary Stille AB (Stille) develops and manufactures surgical instruments, specialty operating tables, headlights and retractor systems. The company offers instruments and specialty tables for cardiovascular and thoracic surgery, neuro surgery, general surgery, orthopedic surgery, plastic surgery, u …
  • Rockwool International AS:戦略・SWOT・企業財務分析
    Rockwool International AS - Strategy, SWOT and Corporate Finance Report Summary Rockwool International AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • OncBioMune Pharmaceuticals Inc (OBMP):製薬・医療:M&Aディール及び事業提携情報
    Summary OncBioMune Pharmaceuticals Inc (OncBioMune), formerly Quint Media Inc is a biopharmaceutical company that develops novel cancer immunotherapy products. The company’s products comprise biosimilars and vaccines developed for cancer types such as renal, breast, prostrate, and ovarian cancer. It …
  • VSE Corporation (VSEC):企業の財務・戦略的SWOT分析
    VSE Corporation (VSEC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • FUJIFILM Holdings Corporation:企業の戦略・SWOT・財務分析
    FUJIFILM Holdings Corporation - Strategy, SWOT and Corporate Finance Report Summary FUJIFILM Holdings Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Co.don AG (CNWK):医療機器:M&Aディール及び事業提携情報
    Summary Co.don AG (Co.don) offers tissue engineering solutions in cultivation and growth of autologous tissue cells for the regenerative treatment of articular cartilage defects and spinal disc defects. The company manufactures and markets autologous, cell-based pharmaceutical products for biologica …
  • CHC Group Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary CHC Group Ltd (CHC) is a provider of helicopter services. The company offers various services including offshore transportation; search and rescue in challenging and hostile environments, from remote, perilous, and extreme terrains to offshore rescues; maintenance, repair, and overhaul; and …
  • ITT Inc.:企業の戦略・SWOT・財務分析
    ITT Inc. - Strategy, SWOT and Corporate Finance Report Summary ITT Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆